Cannabinoids — page 3

A 2026 scoping review of 28 RCTs across 12 DSM-5 conditions. Where cannabinoids show benefit, where evidence is thin, and what we still don't know.

A 2026 longitudinal study of 11,000+ youth shows THC exposure tracks with measurable brain trajectory changes — while CBD does not. The data parents need.

The first randomized trial of cannabis for acute migraine: vaporized THC+CBD flower beat placebo for pain freedom at 2 hours. What the science actually says.

Cannabis flavonoids — especially cannflavin A — match ibuprofen for anti-inflammatory potency. The third bioactive category most consumers have never heard of.

The UK Medical Cannabis Registry tracked 698 patients prescribed cannabis for depression. Mood, sleep, and anxiety all improved — with one important caveat.

A 2026 study: cannabis works better for chronic pain when it ALSO improves sleep, stress, and mood. Why multi-system effects matter — and how to use them.

A 2026 study found CBD reverses nicotine-induced glymphatic system damage in animal models. The neuroscience and the practical takeaway for vapers.

CBD has poor bioavailability — only 6-19% reaches your bloodstream. New nanoparticle research could change that, opening doors to stroke therapy.

A 2026 study of 1,400 chronic pain patients found balanced THC:CBD ratios outperform THC-dominant or CBD-dominant. The science of finding your sweet spot.

Delta-8 and other hemp-derived THC products cause more severe pediatric outcomes than regulated cannabis. The data parents need — and the steps that work.

Tetraploid cannabis plants carry double the chromosomes of normal plants. Here's what polyploid breeding actually does to potency, terpenes, and your flower.

A 2026 cohort of 954 patients found alcohol roughly doubles brain aneurysm rupture risk while cannabis showed no significant link. The data, with caveats.

A 2026 Lancet Psychiatry meta-analysis pooled 54 RCTs of cannabinoid mental health treatments. Signals, null results, and the GRADE-rated honest verdict.

Your brain makes its own cannabinoid called 2-AG. New research shows it controls dopamine-driven decisions — and why this matters for cannabis users.

CBD and THC can spike warfarin INR levels dangerously. Learn the CYP450 mechanism, documented case reports, DOAC risks, and what to tell your doctor.

Explore what research says about cannabis and OCD, from endocannabinoid science to practical considerations for managing obsessive-compulsive symptoms.

What surgeons and anesthesiologists now know about cannabis use before and after operations—anesthesia interactions, pain management, and when to disclose.

What does science say about HHC? Learn how hexahydrocannabinol works, its safety profile, epimer ratios, drug test risks, and 2026 legal status.

How nano-emulsification shrinks THC into nanoparticles for 5x better absorption, 15-min onset, and more predictable dosing than traditional edibles.

THCP binds CB1 receptors 33x more strongly than THC. Discover the 2019 Italian discovery, the chemistry, and what it really means for your cannabis experience.

Your brain makes its own cannabis-like molecule. Here's how anandamide—the bliss molecule—works, why it exists, and what it means for your high.

Your bones have cannabinoid receptors. What research reveals about CBD, CB2 signaling, and whether cannabis can support bone density and fracture healing.

Explore the science of how THC, CBD, and your endocannabinoid system interact with cortisol and the HPA axis stress response.

What science says about cannabinoids and endometriosis pain—from ECS dysfunction to clinical findings and practical guidance for patients.